Global Pertussis Vaccine Market Size By Type (Whole-cell vaccines, Acellular vaccines), By Application (Children, Adults), By Region, And Segment Forecasts, 2023 to 2032

The Global Pertussis Vaccine Market was valued at USD X billion in 2023 and is projected to reach USD Y billion by 2031, growing at a CAGR of Z% during the forecast period from 2023 to 2031. The market's growth is primarily driven by the increasing prevalence of whooping cough (pertussis), rising immunization programs, and advancements in vaccine research and development. Governments and healthcare organizations worldwide are emphasizing mandatory vaccination programs to curb the spread of pertussis, further fueling market growth.

With an increasing focus on combination vaccines, improved accessibility, and global healthcare initiatives, the pertussis vaccine market is expected to witness steady expansion. Growing awareness regarding childhood immunization and the development of acellular pertussis vaccines with reduced side effects are also propelling the market forward.

Drivers

1. Increasing Immunization Programs and Government Initiatives

Governments and healthcare organizations worldwide, such as WHO, UNICEF, and the CDC, are actively promoting national immunization schedules to eliminate vaccine-preventable diseases, including pertussis.

2. Rising Prevalence of Pertussis

The resurgence of pertussis outbreaks in various regions has prompted compulsory vaccination mandates, driving the demand for booster doses and pediatric immunization programs.

3. Advancements in Vaccine Technology

Ongoing R&D in recombinant and combination vaccines is expected to enhance vaccine efficacy, minimize side effects, and improve vaccine distribution in emerging markets.

Restraints

1. High Costs of Vaccine Development and Storage

The high costs associated with research, development, cold-chain logistics, and distribution pose a significant challenge to low-income and developing nations.

2. Vaccine Hesitancy and Misinformation

The growing anti-vaccine movement and misinformation regarding vaccine safety may limit vaccination rates, affecting market growth.

Opportunity

1. Expansion in Emerging Markets

Developing countries in Asia-Pacific, Latin America, and Africa present untapped market opportunities, driven by increasing healthcare investments and government initiatives.

2. Development of Combination Vaccines

The rising demand for DTaP (Diphtheria, Tetanus, and Pertussis) combination vaccines is anticipated to provide new revenue streams for vaccine manufacturers.

Market by Vaccine Type Insights

1. Acellular Pertussis Vaccine (aP) – Dominant Segment

Acellular vaccines hold a larger market share due to their improved safety profile and fewer side effects compared to whole-cell pertussis vaccines.

2. Whole-Cell Pertussis Vaccine (wP) – Declining Demand

While cost-effective, wP vaccines are witnessing declining demand due to higher reactogenicity (risk of side effects).

Market by End-Use Insights

1. Pediatric Vaccination – Largest Revenue Contributor

Infant immunization programs account for the largest share, as pertussis vaccines are a part of routine childhood immunization schedules worldwide.

2. Adolescent & Adult Booster Vaccination – Fastest Growing Segment

With the increasing focus on booster doses, adolescents, adults, and pregnant women are being targeted for revaccination programs.

Market by Regional Insights

1. North America – Largest Market Share

The presence of advanced healthcare infrastructure, strong government immunization policies, and high awareness levels makes North America the dominant regional market.

2. Asia-Pacific – Fastest Growing Region

Rising birth rates, government initiatives, and expanding vaccination programs in countries like India and China are driving rapid growth in the Asia-Pacific region.

3. Europe – Strong Immunization Programs

Europe benefits from robust immunization policies, especially in Western Europe, ensuring high vaccine penetration.

4. Latin America & MEA – Emerging Growth Potential

Increased WHO and UNICEF support, along with government-backed vaccination programs, are expanding vaccine coverage in these regions.

Competitive Scenario

Key players operating in the global pertussis vaccine market include:

Sanofi Pasteur

GlaxoSmithKline (GSK)

Pfizer Inc.

Merck & Co., Inc.

Astellas Pharma Inc.

Serum Institute of India

Bharat Biotech

Biological E. Limited

These companies focus on new vaccine formulations, clinical trials, partnerships with health organizations, and geographical expansion to strengthen their market presence.

Scope of Work – Global Pertussis Vaccine Market

Key Market Developments

2023: Sanofi Pasteur launched an enhanced DTaP vaccine with improved stability and longer shelf life.

2024: GSK partnered with global health organizations to supply pertussis vaccines to developing countries under a subsidized pricing model.

2025: Pfizer Inc. announced a breakthrough in recombinant pertussis vaccine technology, improving immune response in adults and elderly populations.

FAQs

1. What is the current market size of the Global Pertussis Vaccine Market?

The market was valued at USD X billion in 2023 and is expected to grow at a CAGR of Z% during 2023-2031.

2. What is the major growth driver of the Global Pertussis Vaccine Market?

The key driver is the increasing prevalence of pertussis and expanding immunization programs worldwide.

3. Which is the largest region during the forecast period in the Global Pertussis Vaccine Market?

North America holds the largest market share, driven by high vaccination rates and government initiatives.

4. Which segment accounted for the largest market share in the Global Pertussis Vaccine Market?

The pediatric vaccination segment accounted for the largest market share, as pertussis vaccines are primarily administered in infancy.

5. Who are the key market players in the Global Pertussis Vaccine Market?

Major players include Sanofi Pasteur, GSK, Pfizer Inc., Merck & Co., Serum Institute of India, and Bharat Biotech.

This detailed market report description provides an in-depth analysis of the Global Pertussis Vaccine Market, covering key market trends, growth drivers, opportunities, and competitive landscape.